Holen Sie sich die Stockscreener-App
0.4652
9.07%
-0.0464
Vorhandelsmarkt:
.50
0.0348
+7.48%
Schlusskurs vom Vortag:
$0.5116
Offen:
$0.515
24-Stunden-Volumen:
1.14M
Relative Volume:
0.76
Marktkapitalisierung:
$66.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
-0.3446
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
-9.02%
1M Leistung:
-1.02%
6M Leistung:
-3.49%
1J Leistung:
-91.84%
1-Tages-Spanne:
$0.4603
$0.515
1-Wochen-Bereich:
$0.4603
$0.5339
52-Wochen-Spanne:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Firmenname
Applied Therapeutics Inc
Sektor
Branche
Telefon
212-220-9226
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Vergleichen Sie APLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.4652 | 74.90M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Eingeleitet | William Blair | Outperform |
| 2024-03-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-22 | Eingeleitet | Leerink Partners | Outperform |
| 2022-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Herabstufung | Goldman | Neutral → Sell |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-04-22 | Eingeleitet | Goldman | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-06-10 | Eingeleitet | Citigroup | Buy |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
| 2019-06-10 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
Propel Bio Management LLC Has $5.52 Million Stock Position in Applied Therapeutics Inc. $APLT - MarketBeat
Can Applied Therapeutics Inc. grow without external fundingJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - khodrobank.com
Why is Applied Therapeutics Inc. stock going down2025 Price Action Summary & Daily Profit Maximizing Trade Tips - khodrobank.com
Relative strength of Applied Therapeutics Inc. in sector analysis2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Chart based analysis of Applied Therapeutics Inc. trendsLayoff News & Fast Momentum Entry Tips - Newser
Will Applied Therapeutics Inc. stock go up soonDay Trade & Expert Approved Trade Ideas - Newser
Can Applied Therapeutics Inc. ride the EV waveWeekly Profit Recap & High Return Stock Watch Alerts - khodrobank.com
Institutional scanner results for Applied Therapeutics Inc.CPI Data & Weekly Top Performers Watchlists - Newser
Is Applied Therapeutics Inc. gaining market share2025 Volatility Report & Target Return Focused Stock Picks - khodrobank.com
Pullback Watch: How does Applied Therapeutics Inc. score in quality rankingsDollar Strength & Breakout Confirmation Alerts - khodrobank.com
Applied Therapeutics, Inc. shares fall 2.69% intraday as Smith+Nephew launches CENTRIO PRP System. - AInvest
Published on: 2025-09-03 12:33:27 - Newser
What earnings revisions data tells us about Applied Therapeutics Inc.July 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Aug Analyst Calls: Can Applied Therapeutics Inc. maintain sales growth2025 Pullback Review & Long-Term Growth Portfolio Plans - khodrobank.com
Will Applied Therapeutics Inc. benefit from macro trends2025 Price Targets & Smart Allocation Stock Reports - Newser
Identifying reversal signals in Applied Therapeutics Inc.Quarterly Trade Summary & Weekly High Return Stock Opportunities - Newser
Can Applied Therapeutics Inc. rally from current levelsJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Applied Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Outlook & Free Safe Capital Growth Stock Tips - Newser
Should you hold or exit Applied Therapeutics Inc. nowTrade Entry Report & Accurate Technical Buy Alerts - Newser
Published on: 2025-09-02 23:14:31 - Newser
How to build a custom watchlist for Applied Therapeutics Inc.Bull Run & Real-Time Chart Breakout Alerts - Newser
How hedge fund analytics apply to Applied Therapeutics Inc. stockJuly 2025 Big Picture & Technical Buy Zone Confirmations - Newser
Sentiment analysis tools applied to Monopar Therapeutics Inc.Market Risk Summary & Growth Focused Investment Plans - Newser
Is a relief rally coming for Applied Therapeutics Inc. holdersTrade Exit Summary & Proven Capital Preservation Tips - Newser
Aug Update: Is Applied Therapeutics Inc. likely to announce a buyback2025 EndofYear Setup & Free Reliable Trade Execution Plans - khodrobank.com
Visual trend scoring systems applied to Dermata Therapeutics Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser
Sentiment analysis tools applied to Edgewise Therapeutics Inc.Portfolio Update Summary & Smart Investment Allocation Insights - Newser
Is Applied Therapeutics Inc. likely to announce a buybackWeekly Trend Recap & Consistent Income Trade Ideas - khodrobank.com
What recovery options are there for Applied Therapeutics Inc.2025 Risk Factors & Expert Approved Trade Ideas - Newser
Live market analysis of Applied Therapeutics Inc.Weekly Gains Report & Free Daily Entry Point Trade Alerts - Newser
Order Flow Trends Show Accumulation in Applied Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Backtesting results for Applied Therapeutics Inc. trading strategiesSell Signal & Free Safe Capital Growth Stock Tips - Newser
Multi factor analysis applied to LENZ Therapeutics Inc.CPI Data & Proven Capital Preservation Methods - Newser
Price momentum metrics for Applied Therapeutics Inc. explainedQuarterly Earnings Summary & Long-Term Capital Growth Strategies - Newser
Multi factor analysis applied to Tenax Therapeutics Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser
Detecting support and resistance levels for Applied Therapeutics Inc.Trade Volume Report & Consistent Return Strategy Ideas - Newser
Will Applied Therapeutics Inc. bounce back from current supportJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
Forecasting Applied Therapeutics Inc. price range with options dataMarket Movement Recap & High Conviction Buy Zone Alerts - Newser
AI Indicators Detect Buy Opportunity in Applied Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Applied Therapeutics Inc. Price Holds Above Key Fib Level2025 AllTime Highs & Real-Time Stock Movement Alerts - beatles.ru
Visual analytics tools that track Applied Therapeutics Inc. performanceBond Market & Weekly High Potential Stock Alerts - Newser
Chart based exit strategy for Applied Therapeutics Inc.Weekly Investment Summary & Real-Time Buy Zone Alerts - Newser
Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Applied Therapeutics Inc-Aktie (APLT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):